Last updated on April 2018

LimPrOn: Limburg Pre-eclampsia Investigation


Brief description of study

Background

Multiple adaptations at the cardiovascular system occurs during pregnancy. In the pregnancy condition pre-eclampsia (PE), this adaptations are abnormal. Five to eight percent of all pregnant women worldwide will develop PE.

PE is a pregnancy condition which is characterized with a high blood pressure (>140/90 mm Hg) and the occurrence of proteinuria (>3g/dl/24h) after 20 weeks of gestation. When untreated, this condition can have severe complications for both mother and child. It's important to monitor women with a high risk for developing PE for an early detection and treatment of this condition.

For this reason, a multicenter study is set up with the following applications:

  1. NICCOMO and Maternal Venous Doppler Echography: impedance cardiograph and an echography of the heart and veins.
  2. Maltron: bio-electronic impedance analyze
  3. Remote monitoring of the high risk patients to become a more intensive follow-up

Number of inclusions: 1000 pregnant women from the prenatal consultations of eight different

hospitals

Clinical Study Identifier: NCT03509272

Contact Investigators or Research Sites near you

Start Over

Dorien Lanssens, drs.

Ziekenhuis Maas en Kempen
Bree, Belgium
  Connect »

Dorien Lanssens, drs.

Ziekenhuis Oost-Limburg
Genk, Belgium
  Connect »

Dorien Lanssens, drs.

Jessa Ziekenhuis
Hasselt, Belgium
  Connect »

Doriend Lanssens, drs.

Sint-Fransiscus Ziekenhuis
Heusden-Zolder, Belgium
  Connect »

Dorien Lanssens, drs.

Heilig Hart Ziekenhuis
MOL, Belgium
  Connect »

Dorien Lanssens, drs.

Mariaziekenhuis Oost-Limburg
Overpelt, Belgium
  Connect »

Dorien Lanssens, drs.

Sint-Trudo ziekenhuis
Sint-Truiden, Belgium
  Connect »

Dorien Lanssens, drs.

AZ-vesalius
Tongeren, Belgium
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.